日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The human RIF1-Long isoform interacts with BRCA1 to promote recombinational fork repair under DNA replication stress

人类RIF1-Long亚型与BRCA1相互作用,在DNA复制压力下促进重组叉修复。

Qianqian Dong ,Matthew Day ,Yuichiro Saito ,Emma Parker ,Lotte P Watts ,Masato T Kanemaki ,Antony W Oliver ,Laurence H Pearl ,Shin-Ichiro Hiraga ,Anne D Donaldson

Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers

自分泌干扰素中毒介导 BRCA1/2 突变癌症中 ADAR1 依赖性合成致死

Roman M Chabanon ,Liudmila Shcherbakova ,Magali Lacroix-Triki ,Marine Aglave ,Jean Zeghondy ,Victor Kriaa ,Antoine Gougé ,Marlène Garrido ,Elodie Edmond ,Ludovic Bigot ,Dragomir B Krastev ,Rachel Brough ,Stephen J Pettitt ,Thibault Thomas-Bonafos ,Robert Samstein ,Christophe Massard ,Marc Deloger ,Andrew Nj Tutt ,Fabrice Barlesi ,Yohann Loriot ,Suzette Delaloge ,Marcel Tawk ,Cindy Degerny ,Yea-Lih Lin ,Barbara Pistilli ,Philippe Pasero ,Christopher J Lord ,Sophie Postel-Vinay

GSK3B directs DNA repair choice and determines tumor response to PARP1 inhibition independent of BRCA1

GSK3B 指导 DNA 修复选择,并独立于 BRCA1 决定肿瘤对 PARP1 抑制剂的反应。

Heba S Allam ,Scarlett Acklin-Wehnert ,Ratan Sadhukhan ,Mousumi Patra ,Fen Xia

Targeting the ATM-TRMT10A-BRCA1 axis confers synthetic lethality to PARP inhibition in metastatic castration-resistant prostate cancer

靶向 ATM-TRMT10A-BRCA1 轴可使 PARP 抑制剂在转移性去势抵抗性前列腺癌中产生合成致死效应

Ying Yang ,Qiang Liu ,Xinyan Li ,Hua Zhang ,Xin Xu ,Qi Ma ,Somaira Nowsheen ,Khaled Aziz ,Ye-Xiong Li ,Zhenkun Lou ,Qiuzi Zhong ,Min Deng

Radiation-guided nanoparticles enhance the efficacy of PARP inhibitors in primary and metastatic BRCA1-deficient tumors via immunotherapy

辐射引导的纳米颗粒通过免疫疗法增强PARP抑制剂在原发性和转移性BRCA1缺陷型肿瘤中的疗效。

Rami Khoury ,Giuseppe Longobardi ,Tania T Barnatan ,Dana Venkert ,América García Alvarado ,Adi Yona ,Marina Green Buzhor ,Shir Shahar ,Qiwei Wang ,Rita C Acúrcio ,Rita C Guedes ,Helena F Florindo ,Jean J Zhao ,Ronit Satchi-Fainaro

The CLCA1/TMEM16A/Cl- current axis associates with H2S deficiency in diabetic kidney injury

CLCA1/TMEM16A/Cl-电流轴与糖尿病肾损伤中的H2S缺乏有关

Hak Joo Lee ,Yuyang Sun ,Falguni Das ,Wenjun Ju ,Viji Nair ,Christopher G Kevil ,Shankara Varadarajan ,Guanshi Zhang ,Goutam Ghosh Choudhury ,Brij B Singh ,Matthias Kretzler ,Robert G Nelson ,Kumar Sharma ,Balakuntalam S Kasinath

LXRα agonists ameliorates acute rejection after liver transplantation via ABCA1/MAPK and PI3K/AKT/mTOR signaling axis in macrophages

LXRα激动剂通过巨噬细胞中的ABCA1/MAPK和PI3K/AKT/mTOR信号通路减轻肝移植后的急性排斥反应

Xiaoyan Qin ,Dingheng Hu ,Qi Li ,Shiyi Zhang ,Zheng Qin ,Liangxu Wang ,Rui Liao ,Zhongjun Wu ,Yanyao Liu

IL-6 Blockade Enhances the Efficacy of CDK4/6 Inhibitor in BRCA1-Mutant Triple-Negative Breast Cancer Cells

IL-6阻断增强CDK4/6抑制剂对BRCA1突变三阴性乳腺癌细胞的疗效

Li Pan ,Changyou Shi ,Joungil Choi ,Jiayuh Lin

PROCA11 early activation fuels prostate cancer neuroendocrine traits by regulating cell survival and migration

PROCA11早期激活通过调节细胞存活和迁移,促进前列腺癌的神经内分泌特征。

Rocco Cipolla ,Marc Gabriel ,Ugo Szachnowski ,Zhimin Wang ,Martina Romani ,Giorgia Ianese Regin ,Micaela Piemontese ,Virginie Firlej ,Marina Pinskaya ,Antonin Morillon

Using a brain-like endothelial cell differentiation to characterize the CS79iBRCA-n2 BRCA1 mutated patient derived stem cell line

利用类脑内皮细胞分化来表征 CS79iBRCA-n2 BRCA1 突变患者来源的干细胞系

Natalie G Alexander ,Kylie A Buchanan ,Alexandra E Meyer ,Lauren M Mitterway ,Caroline O Vanderburgh ,Shreyas S Rao ,Brandon J Kim